Posted in | News | 3D Printing

Interfacial Solutions to be Acquired by Stratasys

Stratasys Ltd., a leading global provider of additive manufacturing solutions, today announced that it has entered into a definitive asset purchase agreement to acquire certain assets of Wisconsin-based Interfacial Solutions.

Interfacial Solutions, a provider of thermoplastics R&D and production services, has been a production partner to Stratasys for its FDM product lines over the past three years. It has been instrumental in the research and development for, and is the producer of, some of Stratasys’ thermoplastic material.

“Interfacial Solutions provides significant expertise in plastics and filament,” says David Reis, CEO of Stratasys. “We believe its knowledgeable team and experience will accelerate Stratasys’ materials development efforts for all of our FDM platforms, including MakerBot. The acquisition is expected to accomplish three objectives for Stratasys, which include strengthening our materials R&D skills and bandwidth; enabling us to become vertically integrated in material development and manufacturing; and increasing materials production space and capacity. Overall, we expect to accelerate new materials development, allowing us to introduce new products to the market faster.”

Stratasys expects the transaction to close in the second quarter of 2014, subject to the fulfillment of certain customary closing conditions.

Stratasys Ltd. (Nasdaq: SSYS), headquartered in Minneapolis, Minn. and Rehovot, Israel, manufactures 3D printers and materials for prototyping and production. The company’s patented FDM® and PolyJetTM 3D Printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape, and the company operates the RedEye digital-manufacturing service. Stratasys has more than 1800 employees, holds over 550 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership. Online at: www.stratasys.com or http://blog.stratasys.com

Interfacial Solutions LLC is a privately held contract research and development technology company with a proven track record of helping innovators innovate in the material science field. Located in a 42,000 square foot facility near River Falls, Wisconsin, Interfacial Solutions has a creative team of scientists possessing more than 50 issued patents and is equipped with state-of-the-art polymer testing equipment, compound and processing equipment, and production capabilities to meet a broad range of plastic industry challenges. Additional information can be found at http://www.interfacialsolutions.com.

Stratasys and FDM are registered trademarks of Stratasys Ltd and or its subsidiaries or affiliates.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Stratasys Ltd.. (2019, February 08). Interfacial Solutions to be Acquired by Stratasys. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=40747.

  • MLA

    Stratasys Ltd.. "Interfacial Solutions to be Acquired by Stratasys". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=40747>.

  • Chicago

    Stratasys Ltd.. "Interfacial Solutions to be Acquired by Stratasys". AZoM. https://www.azom.com/news.aspx?newsID=40747. (accessed November 21, 2024).

  • Harvard

    Stratasys Ltd.. 2019. Interfacial Solutions to be Acquired by Stratasys. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=40747.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.